These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Imaging metabolism and biochemistry--a new look at the heart. Schelbert HR; Phelps ME; Shine KI Am Heart J; 1983 Mar; 105(3):522-6. PubMed ID: 6600873 [No Abstract] [Full Text] [Related]
8. [Positron computed tomography: a new method for quantitative determination of cardiac metabolism, blood circulation and function. I. Technical and experimental bases]. Schön HR; Schelbert HR; Phelps ME Nuklearmedizin; 1983 Aug; 22(4):171-80. PubMed ID: 6356039 [TBL] [Abstract][Full Text] [Related]
9. Limitations of myocardial FDG studies. McFalls EO Circulation; 1995 Nov; 92(10):3145. PubMed ID: 7586289 [No Abstract] [Full Text] [Related]
10. Positron emission tomography of the heart. Bergmann SR; Fox KA; Geltman EM; Sobel BE Prog Cardiovasc Dis; 1985; 28(3):165-94. PubMed ID: 3877316 [No Abstract] [Full Text] [Related]
11. Positron emission tomography in the diagnosis and management of coronary artery disease. Bratton NG J La State Med Soc; 1995 May; 147(5):193-6. PubMed ID: 7782672 [TBL] [Abstract][Full Text] [Related]
12. [Assessment of myocardial circulation and metabolism using positron CT]. Shishido F; Uemura K; Kanno I; Murakami M; Ono Y; Takahashi A J Cardiol Suppl; 1987; 15():61-3. PubMed ID: 3509906 [TBL] [Abstract][Full Text] [Related]
13. Increased fluorine-18 deoxyglucose uptake after percutaneous transluminal coronary angioplasty in recently infarcted myocardium. Hashimoto T; Kambara H; Fudo T; Nohara R; Hayashi M; Takatsu Y; Tamaki N; Konishi J; Kawai C Am J Cardiol; 1989 Mar; 63(11):743-4. PubMed ID: 2522272 [No Abstract] [Full Text] [Related]
14. Metabolism and blood flow as new markers of myocardial viability in the evolution of myocardial infarction. Schwaiger M Eur J Nucl Med; 1986; 12 Suppl():S62-5. PubMed ID: 3490380 [TBL] [Abstract][Full Text] [Related]
15. Clinical and economic controversies in radionuclide assessment of myocardial viability. Alagona P Circulation; 1995 Nov; 92(10):3145-6. PubMed ID: 7586290 [No Abstract] [Full Text] [Related]
16. C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. Schelbert HR; Henze E; Schon HR; Keen R; Hansen H; Selin C; Huang SC; Barrio JR; Phelps ME Am Heart J; 1983 Mar; 105(3):492-504. PubMed ID: 6600872 [No Abstract] [Full Text] [Related]
17. [Assessment of myocardial energy metabolism with PET]. Kinoshita S; Serizawa T Nihon Rinsho; 1997 Mar; 55 Suppl 1():644-7. PubMed ID: 9097693 [No Abstract] [Full Text] [Related]
18. Regional heterogeneity of cardiac substrate metabolism? Schwaiger M; Hicks R J Nucl Med; 1990 Nov; 31(11):1757-60. PubMed ID: 2230988 [No Abstract] [Full Text] [Related]
19. Detection of myocardial viability with positron emission tomography in a patient with ischemic cardiomyopathy. J Nucl Med; 1991 Jan; 32(1):130-5. PubMed ID: 1988617 [No Abstract] [Full Text] [Related]
20. Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography. Hicks RJ; Herman WH; Kalff V; Molina E; Wolfe ER; Hutchins G; Schwaiger M J Am Coll Cardiol; 1991 Jul; 18(1):101-11. PubMed ID: 2050912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]